Generation Bio (GBIO) Price & Analysis

Compare

245 Followers

GBIO Stock Chart & Stats

Day’s Range― - ―

52-Week Range$3.00 - $27.40

Previous CloseN/A

Volume226.22K

Average Volume (3M)552.29K

Market Cap

$38.80M

Enterprise Value-$34.58M

Total Cash (Recent Filing)$141.36M

Total Debt (Recent Filing)$85.32M

Price to Earnings (P/E)―

Beta2.74

Next Earnings

Nov 05, 2025

EPS Estimate

-3.15

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-3.12

Shares Outstanding6,735,544

10 Day Avg. Volume70,330

30 Day Avg. Volume552,289

Financial Highlights & Ratios

PEG Ratio-0.81

Price to Book (P/B)0.82

Price to Sales (P/S)3.55

P/FCF Ratio-0.78

Enterprise Value/Market Cap-0.89

Enterprise Value/Revenue-1.63

Enterprise Value/Gross Profit-1.63

Enterprise Value/Ebitda0.49

Forecast

1Y Price Target

$11.00

Price Target Upside92.31% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering6

Bulls Say, Bears Say

Bulls Say

Financial StabilityAnalysts note the significant cash balance of Generation Bio, expected to last into the foreseeable future, highlighting financial stability.

Innovative TechnologyGeneration Bio's new in vivo NHP results represent a major milestone for its ctLNP platform, demonstrating successful siRNA delivery to T cells without inducing activation.

Bears Say

Strategic UncertaintyThere is increased uncertainty around Generation Bio's path forward and potential ability to achieve strategic goals as it explores alternatives.

Workforce ReductionGeneration Bio announced a significant reduction in its workforce by 90% as part of its exploration of strategic alternatives, indicating operational changes.

Generation Bio News

Generation Bio price target raised to $10 from $9 at Canaccord

Canaccord raised the firm’s price target on Generation Bio (GBIO) to $10 from $9 and keeps a Buy...

1M ago

GBIO

Generation Bio Co. Warns Stakeholders of Persistent Business Risks in 2024 Report

Generation Bio Co. (GBIO) has disclosed a new risk, in the Regulation category. Generation Bio Co. faces significant...

1M ago

GBIO

Generation Bio’s Promising siRNA Delivery and Financial Stability Justify Buy Rating Despite Workforce Reductions

Analyst Gil Blum of Needham maintained a Buy rating on Generation Bio, with a price target of $15.00....

1M ago

GBIO

Wedbush downgrades Generation Bio as company seeks strategic alternatives

As previously reported, Wedbush analyst David Nierengarten downgraded Generation Bio (GBIO) to Neutral from Outperform with a $7...

1M ago

GBIO

Generation Bio downgraded to Neutral from Outperform at Wedbush

Wedbush downgraded Generation Bio (GBIO) to Neutral from Outperform with a $7 price target Published first on TheFly...

1M ago

GBIO

Generation Bio Co. Reports Promising Data and Financial Results

Generation Bio Co. ( ($GBIO) ) has released its Q2 earnings. Here is a breakdown of the information...

1M ago

GBIO

Generation Bio: Promising Scientific Advances Amidst Strategic Uncertainty

TD Cowen analyst Brendan Smith has maintained their neutral stance on GBIO stock, giving a Hold rating on...

2M ago

GBIO

Generation Bio trading halted, news pending

19:50 EDT Generation Bio (GBIO) trading halted, news pending Published first on TheFly – the ultimate source for...

2M ago

GBIO

Upcoming Stock Splits This Week (July 21 to July 25) – Stay Invested

These are the upcoming stock splits for the week of July 21 to July 25 on TipRanks’ Stock Splits...

2M ago

GVH

Generation Bio Announces Reverse Stock Split

Generation Bio ( ($GBIO) ) just unveiled an update. On July 18, 2025, Generation Bio announced a 1-for-10...

2M ago

GBIO

Generation Bio announces 1-for-10 reverse stock split

Generation Bio (GBIO) will implement a 1-for-10 reverse stock split of the issued shares of the Company’s common...

2M ago

GBIO

Generation Bio Elects Directors and Approves Key Proposals

Generation Bio ( ($GBIO) ) has shared an announcement. On June 4, 2025, Generation Bio Co. conducted its...

4M ago

GBIO

Generation Bio Co. Reports Reduced Losses and Increased Revenue

Generation Bio Co. ( ($GBIO) ) has released its Q1 earnings. Here is a breakdown of the information...

5M ago

GBIO

Buy Rating for Generation Bio: Strategic Focus on siRNA Therapeutics and Innovative T-Cell Delivery

Generation Bio (GBIO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today....

5M ago

GBIO

GBIO FAQ

What was Generation Bio Co.’s price range in the past 12 months?

Generation Bio Co. lowest stock price was $3.00 and its highest was $27.40 in the past 12 months.

What is Generation Bio Co.’s market cap?

Generation Bio Co.’s market cap is $38.80M.

When is Generation Bio Co.’s upcoming earnings report date?

Generation Bio Co.’s upcoming earnings report date is Nov 05, 2025 which is in 40 days.

How were Generation Bio Co.’s earnings last quarter?

Generation Bio Co. released its earnings results on Aug 12, 2025. The company reported -$3.12 earnings per share for the quarter, missing the consensus estimate of -$2.848 by -$0.272.

Is Generation Bio Co. overvalued?

According to Wall Street analysts Generation Bio Co.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Generation Bio Co. pay dividends?

Generation Bio Co. does not currently pay dividends.

What is Generation Bio Co.’s EPS estimate?

Generation Bio Co.’s EPS estimate is -3.15.

How many shares outstanding does Generation Bio Co. have?

Generation Bio Co. has 6,735,544 shares outstanding.

What happened to Generation Bio Co.’s price movement after its last earnings report?

Generation Bio Co. reported an EPS of -$3.12 in its last earnings report, missing expectations of -$2.848. Following the earnings report the stock price went up 63.21%.

Which hedge fund is a major shareholder of Generation Bio Co.?

Currently, no hedge funds are holding shares in GBIO

Generation Bio Stock Smart Score

Neutral

Fundamentals

Return on Equity

-85.45%

Trailing 12-Months

Asset Growth

-32.36%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Generation Bio Co.

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Generation Bio (GBIO) Earnings & Revenues

Historic Earnings Reports

GBIO Stock 12 Month Forecast

Average Price Target

$11.00

▲(92.31% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","17":"$17","32":"$32","9.5":"$9.5","24.5":"$24.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,9.5,17,24.5,32],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.98,6.673846153846155,7.367692307692308,8.061538461538461,8.755384615384616,9.44923076923077,10.143076923076922,10.836923076923076,11.53076923076923,12.224615384615385,12.918461538461539,13.612307692307692,14.306153846153846,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.98,6.366153846153846,6.752307692307693,7.138461538461539,7.524615384615385,7.910769230769231,8.296923076923077,8.683076923076923,9.069230769230769,9.455384615384617,9.841538461538462,10.227692307692308,10.613846153846154,{"y":11,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.98,6.058461538461539,6.136923076923077,6.2153846153846155,6.293846153846154,6.372307692307692,6.450769230769231,6.52923076923077,6.607692307692308,6.686153846153847,6.764615384615385,6.843076923076923,6.921538461538462,{"y":7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":29.1,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.7,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.6,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.6,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.1,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.6,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.8,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.68,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.4,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.84,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.2,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.21,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.98,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >